Early term outcomes of "2-staged" hybrid coronary revascularization for patients with multivessel coronary artery disease
-
摘要: 目的:观察择期"分站式"杂交手术治疗冠状动脉(冠脉)多支血管病变的早期结果,评价"分站式"杂交手术的可行性、安全性和疗效。方法:选取因冠脉多支血管病变在我院行择期"分站式"杂交手术的患者73例(HCR组),同时随机选取同期、同一术者完成的非体外循环冠脉搭桥手术患者383例(OPCAB组),进行回顾性研究比较。所有患者术后3个月进行电话问卷随访。结果:HCR组在外科手术时间[(152.9±43.8)min︰(262.6±51.8)min, P<0.001]、术后总引流量[(558.6±441.3)ml︰(1 035.5±613.3)ml,P<0.001]、输红细胞[(0.8±1.9)U︰(2.6±4.0)U,P<0.001]、机械通气时间[(10.5±13.0)h︰(30.5±61.3)h,P=0.006]等指标,明显优于OPCAB组;HCR组处理冠脉支数与OPCAB组没有显著区别[(2.6±0.5)︰(2.7±0.5),P=0.101];HCR组小切口冠脉旁路移植术(MIDCAB)与PCI间隔时间(5.3±2.9)d,冠脉植入支架数(1.6±0.7)。两组患者均无住院期间死亡;术后3个月电话随访,均存活,无再入院,无再发脑梗死、心绞痛再发和心肌梗死。结论:"分站式"杂交手术是一种安全、有效的手术方式,其围手术期和早期随访结果满意,更适合于我国国情,适用于合并LAD严重病变无法接受PCI治疗而RCA或(和)LCX等非LAD病变可以进行PCI治疗的冠脉粥样硬化多支病变者。
-
关键词:
- 冠脉血运杂交重建术,"分站式" /
- 经皮冠状动脉介入治疗 /
- 小切口冠状动脉旁路移植术
Abstract: Objective: To compare midterm clinical outcomes of "2-staged" hybrid coronary revascularization (HCR) with off-pump coronary artery bypass grafting (OPCAB) for the treatment of multivessel coronary artery disease. Method: Seventy-three patients who underwent 2-staged HCR because of coronary multivessel lesions were included retrospectively (HCR group).Three hundred and eighty-three other patients who underwent conventional OPCAB by the same surgeon at the same time were selected randomly (OPCAB group). Differences of the clinical data were contrasted between the two groups. Result: The HCR group had less operation duration [(152.9±43.8)min vs (262.6±51.8)min,P<0.001], bleeding [(558.6±441.3)ml vs (1035.5±613.3)ml,P<0.001], mechanical ventilation [(10.5±13.0)h vs (30.5±61.3)h, P<0.006], and blood transfusion [(0.8±1.9)U vs (2.6±4.0)U, P<0.001]. There was no difference between two groups in the postoperative peak of TNI,serum creatinine and post-operative hospital stays.There was no death during hospitalization in both groups. According to the telephone follow-up of 3 months after surgery,there was no death,readmission,cerebral infarction,myocardial infarction and renal failure in both groups.Conclusion: The 2-staged HCR is safe and feasible for performing the multiple coronary artery revascularization. -
-
[1] ANGELINI G D,WILDE P,SALERNO T A,et al.Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularization[J].Lancet,1996,347:757-758.
[2] TATOULIS J,BUXTON B F,FULLER J A.Patencies of 2127arterial to coronary conduits over 15years[J].Ann Thorac Surg,2004,77:93-101.
[3] WEISZ G,LEON M B,JR HOLMES D R,et al.Two-year outcomes after sirolimus-eluting stent implantation:results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions(SIRIUS)trial[J].J Am Coll Cardiol,2006,47:1350-1355.
[4] JAFFERY Z,KOWALSKI M,WEAVER W D,et al.A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery[J].Eur J Cardiothorac Surg,2007,31:691-697.
[5] KIM K B,CHO K R,JEONG D S.Midterm angiographic follow-up after off-pump coronary artery bypass:serial comparison using early,1-year,and 5-year postoperative angiograms[J].J Thorac Cardiovasc Surg,2008,135:300-307.
[6] HANNAN E L,RACZ M,HOLMES D R,et al.Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents[J].Circulation,2008,117:2071-2078.
[7] BYRNE J G,LEACCHE M,VAUGHAN D E,et al.Hybrid cardiovascular procedures[J].JACC Cardiovasc Interv,2008,1:459-468.
[8] VERHAEGH A J,ACCORD R E,VAN GARSSE L,et al.Hybrid coronary revascularization as a safe,feasible,and viable alternative to conventional coronary arterybypass grafting:what is the current evidence?[J].Minim Invasive Surg,2013:142616.
[9] AVGERINOS D V,CHARITAKIS K.Hybrid coronary revascularization:present and future[J].Hellenic J Cardiol,2015,56:193-196.
[10] KANG J,SONG H,LEE S I,et al.Hybrid coronary revascularization using limited incisional full sternotomy coronary artery bypass surgery in multivessel disease:early results[J].Korean J Thorac Cardiovasc Surg,2014,47:106-110.
[11] HALKOS M E,WALKER P F,VASSILIADES T A,et al.Clinical and angiographic results after hybrid coronary revascularization[J].Ann Thorac Surg,2014,97:484-490.
[12] KRAMER R S,QUINN R D,GROOM R C,et al.Same admission cardiac catheterization and cardiac surgery:is there an increased incidence of acute kidney injury?[J].Ann Thorac Surg,2010,90:1418-1424.
[13] HOLZHEY D M,JACOBS S,MOCHALSKI M,et al.Minimally invasive hybrid coronary artery revascularization[J].Ann Thorac Surg,2008,86:1856-1860.
[14] SHEN L,HU S,WANG H,et al.One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease.J Am Coll Cardiol,2013,61:2525-2533.
[15] ZHU P,ZHOU P,SUN Y,et al.Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary arterydisease:systematic review and meta-analysis[J].J Cardiothorac Surg,2015,10:63.
[16] PHAN K,WONG S,WANG N,et al.ybrid coronary revascularization versus coronary artery bypass surgery:systematic review and meta-analysis[J].Int J Cardiol,2015,179:484-488.
[17] HARSKAMP R E,BAGAI A,HALKOS M E,et al.Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery:a metaanalysisof 1,190patients[J].Am Heart J,2014,167:585-592.
[18] HALKOS M E,VASSILIADES T A,DOUGLAS J S,et al.Hybrid coronary revascularization versus offpump coronary artery bypass grafting for the treatment ofmultivessel coronary artery disease[J].Ann Thorac Surg,2011,92:1695-1701.
[19] REPOSSINI A,TESPILI M,SAINO A,et al.Hybrid coronary revascularization in 100 patients with multivessel coronary disease[J].Ann Thorac Surg,2014,98:574-580.
-
计量
- 文章访问数: 102
- PDF下载数: 23
- 施引文献: 0